Ferritin
FTH1proteinFerritin is a systemic marker of oxidative stress and hemolysis associated with myocardial infarction risk and adverse outcomes.
Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencemedium
RationaleSystemic iron-metabolism and oxidative-stress marker; associated with MACE risk.
Also acts inMyocardial injury
Druggability
Not assessed (no mapped human gene target).
Type I vs Type II discrimination
ScoresIndeterminate
R — rupture / Type-I—
C — confounder / Type-II44
A — assay feasibility84
E — evidence strength95
T1DI (composite)28
Specificity differential (R−C)-29.4
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationmag 3
2anemia / acute blood lossn/a
3hypovolemia / dehydrationmag 2
4tachyarrhythmiamag 1
5hypoxemia / respiratory failuremag 0
6hypertensive emergencymag 0
7high-demand / peri-operative stressmag 2
Coverage: 6/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 11 supporting references. See the discrimination table for all markers.
Assay & specimen
Validated clinical assay
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST)
Method / principle
Chemiluminescent/immunoturbidimetric immunoassay
Reagent / substrate
Anti-ferritin antibody pair/latex
Platform
Automated analyzer
Turnaround · availability
Routine · Universal
Literature evidence(2)
- Genetic insights into associations of multisite chronic pain with common diseases and biomarkers using data from the UK Biobank.British journal of anaesthesia · 2023 · PMID 38104003 · doi
- Inflammatory biomarkers and risk of cardiovascular events in patients undergoing coronary angiography.American heart journal · 2022 · PMID 35753356 · doi